Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation
by
Brouns, Elisabeth R.
, Buijze, Marijke
, Brakenhoff, Ruud H.
, Stigter-van Walsum, Marijke
, van Kempen, Britt E.
, Peferoen, Laura
, van der Meij, Erik H.
, Brink, Arjen
, Wils, Leon J.
, Poell, Jos B.
, de Visscher, Jan G. A. M.
, Bloemena, Elisabeth
in
Biopsy
/ Cancer therapies
/ Cell culture
/ cell culture models
/ Cell cycle
/ Cell division
/ Cell growth
/ CRISPR
/ CRISPR-Cas Systems - genetics
/ CRISPR/Cas9
/ Cyclin-Dependent Kinase Inhibitor p16 - genetics
/ Cyclin-Dependent Kinase Inhibitor p16 - metabolism
/ Drugs
/ Genes
/ Genetic Engineering
/ Genetic transformation
/ Genomics
/ Humans
/ Immortalization
/ Keratinocytes
/ Keratinocytes - metabolism
/ Keratinocytes - pathology
/ Leukokeratosis
/ Leukoplakia, Oral - genetics
/ Leukoplakia, Oral - pathology
/ malignant transformation
/ Mouth Mucosa - pathology
/ Mouth Neoplasms - genetics
/ Mouth Neoplasms - pathology
/ Oral cancer
/ Oral cavity
/ oral diseases
/ oral leukoplakia
/ oral squamous cell carcinoma
/ p53 Protein
/ Patients
/ Precancerous Conditions - genetics
/ Precancerous Conditions - pathology
/ Senescence
/ Telomerase
/ Telomerase - genetics
/ Telomerase - metabolism
/ Tumor Suppressor Protein p53 - genetics
/ Tumor Suppressor Protein p53 - metabolism
/ Tumors
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation
by
Brouns, Elisabeth R.
, Buijze, Marijke
, Brakenhoff, Ruud H.
, Stigter-van Walsum, Marijke
, van Kempen, Britt E.
, Peferoen, Laura
, van der Meij, Erik H.
, Brink, Arjen
, Wils, Leon J.
, Poell, Jos B.
, de Visscher, Jan G. A. M.
, Bloemena, Elisabeth
in
Biopsy
/ Cancer therapies
/ Cell culture
/ cell culture models
/ Cell cycle
/ Cell division
/ Cell growth
/ CRISPR
/ CRISPR-Cas Systems - genetics
/ CRISPR/Cas9
/ Cyclin-Dependent Kinase Inhibitor p16 - genetics
/ Cyclin-Dependent Kinase Inhibitor p16 - metabolism
/ Drugs
/ Genes
/ Genetic Engineering
/ Genetic transformation
/ Genomics
/ Humans
/ Immortalization
/ Keratinocytes
/ Keratinocytes - metabolism
/ Keratinocytes - pathology
/ Leukokeratosis
/ Leukoplakia, Oral - genetics
/ Leukoplakia, Oral - pathology
/ malignant transformation
/ Mouth Mucosa - pathology
/ Mouth Neoplasms - genetics
/ Mouth Neoplasms - pathology
/ Oral cancer
/ Oral cavity
/ oral diseases
/ oral leukoplakia
/ oral squamous cell carcinoma
/ p53 Protein
/ Patients
/ Precancerous Conditions - genetics
/ Precancerous Conditions - pathology
/ Senescence
/ Telomerase
/ Telomerase - genetics
/ Telomerase - metabolism
/ Tumor Suppressor Protein p53 - genetics
/ Tumor Suppressor Protein p53 - metabolism
/ Tumors
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation
by
Brouns, Elisabeth R.
, Buijze, Marijke
, Brakenhoff, Ruud H.
, Stigter-van Walsum, Marijke
, van Kempen, Britt E.
, Peferoen, Laura
, van der Meij, Erik H.
, Brink, Arjen
, Wils, Leon J.
, Poell, Jos B.
, de Visscher, Jan G. A. M.
, Bloemena, Elisabeth
in
Biopsy
/ Cancer therapies
/ Cell culture
/ cell culture models
/ Cell cycle
/ Cell division
/ Cell growth
/ CRISPR
/ CRISPR-Cas Systems - genetics
/ CRISPR/Cas9
/ Cyclin-Dependent Kinase Inhibitor p16 - genetics
/ Cyclin-Dependent Kinase Inhibitor p16 - metabolism
/ Drugs
/ Genes
/ Genetic Engineering
/ Genetic transformation
/ Genomics
/ Humans
/ Immortalization
/ Keratinocytes
/ Keratinocytes - metabolism
/ Keratinocytes - pathology
/ Leukokeratosis
/ Leukoplakia, Oral - genetics
/ Leukoplakia, Oral - pathology
/ malignant transformation
/ Mouth Mucosa - pathology
/ Mouth Neoplasms - genetics
/ Mouth Neoplasms - pathology
/ Oral cancer
/ Oral cavity
/ oral diseases
/ oral leukoplakia
/ oral squamous cell carcinoma
/ p53 Protein
/ Patients
/ Precancerous Conditions - genetics
/ Precancerous Conditions - pathology
/ Senescence
/ Telomerase
/ Telomerase - genetics
/ Telomerase - metabolism
/ Tumor Suppressor Protein p53 - genetics
/ Tumor Suppressor Protein p53 - metabolism
/ Tumors
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation
Journal Article
Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation
2024
Request Book From Autostore
and Choose the Collection Method
Overview
Precancerous cells in the oral cavity may appear as oral potentially malignant disorders, but they may also present as dysplasia without visual manifestation in tumor-adjacent tissue. As it is currently not possible to prevent the malignant transformation of these oral precancers, new treatments are urgently awaited. Here, we generated precancer culture models using a previously established method for the generation of oral keratinocyte cultures and incorporated CRISPR/Cas9 editing. The generated cell lines were used to investigate the efficacy of a set of small molecule inhibitors. Tumor-adjacent mucosa and oral leukoplakia biopsies were cultured and genetically characterized. Mutations were introduced in CDKN2A and TP53 using CRISPR/Cas9 and combined with the ectopic activation of telomerase to generate cell lines with prolonged proliferation. The method was tested in normal oral keratinocytes and tumor-adjacent biopsies and subsequently applied to a large set of oral leukoplakia biopsies. Finally, a subset of the immortalized cell lines was used to assess the efficacy of a set of small molecule inhibitors. Culturing and genomic engineering was highly efficient for normal and tumor-adjacent oral keratinocytes, but success rates in oral leukoplakia were remarkably low. Knock-out of CDKN2A in combination with either the activation of telomerase or knock-out of TP53 seemed a prerequisite for immortalization. Prolonged culturing was accompanied by additional genetic aberrations in these cultures. The generated cell lines were more sensitive than normal keratinocytes to small molecule inhibitors of previously identified targets. In conclusion, while very effective for normal keratinocytes and tumor-adjacent biopsies, the success rate of oral leukoplakia cell culturing methods was very low. Genomic engineering enabled the prolonged culturing of OL-derived keratinocytes but was associated with acquired genetic changes. Further studies are required to assess to what extent the immortalized cultures faithfully represent characteristics of the cells in vivo.
Publisher
MDPI AG
Subject
/ CRISPR
/ CRISPR-Cas Systems - genetics
/ Cyclin-Dependent Kinase Inhibitor p16 - genetics
/ Cyclin-Dependent Kinase Inhibitor p16 - metabolism
/ Drugs
/ Genes
/ Genomics
/ Humans
/ Leukoplakia, Oral - genetics
/ Leukoplakia, Oral - pathology
/ oral squamous cell carcinoma
/ Patients
/ Precancerous Conditions - genetics
/ Precancerous Conditions - pathology
/ Tumor Suppressor Protein p53 - genetics
/ Tumor Suppressor Protein p53 - metabolism
/ Tumors
This website uses cookies to ensure you get the best experience on our website.